Two KRAS-targeted strategies are starting to reshape treatment for metastatic pancreatic cancer after decades of limited progress with chemotherapy.

In a randomized trial of patients with left-sided resectable pancreatic cancer, minimally invasive pancreatectomy showed comparable overall survival and disease-free survival to open surgery, ...

Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins ...

Clinical trials at Emory and Piedmont are signaling a potential breakthrough in treating pancreatic cancer, one of the nation ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity who underwent bariatric surgery had ...

(WNDU) - Pancreatic cancer is a stubborn and difficult cancer to treat. In fact, it has the highest death rate of all major cancers. Now, researchers have found a new treatment protocol that may help ...

A new pancreatic cancer treatment may finally move the needle on what's proved to be an unforgiving disease. Fred Hutch ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell Medicine.

Stage 2 pancreatic cancer includes stages 2A and 2B. Stage 2A is when the cancer tumor has grown to over 4 centimeters (cm). Stage 2B is when it has spread from the pancreas to up to three nearby ...

The FDA has given some patients early access to the drug, daraxonrasib. A study being presented at an oncology conference in Chicago show it's the first treatment to considerably extend the lives of ...